ARX-1001

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameARX-1001
Drug Alias NameNcf-1 (Arexis)ARX-1001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeutrophil cytosol factor 1 modulators
TargetsNeutrophil cytosol factor 1
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArexis AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArexis AB
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A